Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

MDPI full text link MDPI Free PMC article
Full text links

Actions

.2025 Jun 20;14(13):4414.
doi: 10.3390/jcm14134414.

Quo Vadis Temporomandibular Disorders? By 2050, the Global Prevalence of TMD May Approach 44

Affiliations

Quo Vadis Temporomandibular Disorders? By 2050, the Global Prevalence of TMD May Approach 44

Grzegorz Zieliński. J Clin Med..

Abstract

Background/objectives: Currently, temporomandibular disorders (TMDs) represent a significant public health concern, affecting approximately 34% of the global population. The primary aim of this study was to determine the prevalence of TMDs in the year 2050. A secondary objective was to estimate the prevalence for the years 2030, 2075, and 2100.

Methods: The methodology of a prognostic study was replicated and adapted to develop prevalence projections for TMDs, utilising the most recent meta-analysis of the global prevalence of temporomandibular disorders and analyses conducted within the R environment.

Results: Projections indicate a gradual increase in the global prevalence of TMDs over the coming decades. In 2030, the estimated prevalence is 39% (95% confidence interval: 34-44%). This figure is expected to rise to 41% [36-46%] by 2040 and reach 44% [39-49%] by 2050. The upward trend continues, with projections suggesting a prevalence of 47% [42-52%] in 2075 and 49% [44-54%] by 2100. These data highlight a steadily increasing global burden of TMDs.

Conclusions: By the year 2050, the global prevalence of TMDs is projected to reach 44%, which, according to estimates, corresponds to approximately 4,252,160,000 individuals. By 2030, 39% of the population is projected to experience TMDs. By 2075, the global TMD prevalence is expected to rise to 47%, and, by 2100, it could increase further to 49% of the global population. Urbanisation affects TMD prevalence in a region-dependent manner; a significant decrease was observed in Asia, while, in the Americas and Europe, the association was negligible. Globally, the lack of a clear impact of urbanisation on TMD occurrence suggests the influence of environmental and cultural factors.

Keywords: 2050; 2075; 2100; TMDs; epidemiology; meta-analysis; prediction; prevalence; temporomandibular disorders; trends.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Figures

Figure 1
Figure 1
Graphical representation of the projected prevalence of TMD for the years 2050, 2075, and 2100, including 95% confidence intervals.
Figure 2
Figure 2
Graphical representation of TMD prevalence for the years 2050, 2075, and 2100 by continent.
See this image and copyright information in PMC

References

    1. Szabolcsi R. Quo Vadis, Domine? Technol. Soc. Sci. J. 2020;9:50–57. doi: 10.47577/tssj.v9i1.964. - DOI
    1. Song H.K. Quo Vadis Experimental Structural Biology? Mol. Cells. 2023;46:71–73. doi: 10.14348/molcells.2023.2197. - DOI - PMC - PubMed
    1. Hazan Ben-Menachem R., Pines O., Saada A. Mitochondrial Derived Vesicles-Quo Vadis? FEBS J. 2024;291:4660–4669. doi: 10.1111/febs.17103. - DOI - PubMed
    1. Gonzalez R.J., von Andrian U.H. Quo Vadis, Neutrophil? Cell. 2022;185:759–761. doi: 10.1016/j.cell.2022.02.009. - DOI - PubMed
    1. Daubner-Bendes R., Kovács S., Niewada M., Huic M., Drummond M., Ciani O., Blankart C.R., Mandrik O., Torbica A., Yfantopoulos J., et al. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges. Front. Public Health. 2020;8:612410. doi: 10.3389/fpubh.2020.612410. - DOI - PMC - PubMed

LinkOut - more resources

Full text links
MDPI full text link MDPI Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp